Nuveen Asset Management, LLC Allogene Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 239,069 shares of ALLO stock, worth $695,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

239,069

Previous 302,255 20.9%

Holding current value

$695,690

Previous $1.35 Million 58.77%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.23 - $4.38 $140,904 - $276,754	-63,186 Reduced 20.9%	239,069 $557,000
Q1 2024 May 13, 2024	SELL	$2.92 - $5.63 $161,484 - $311,355	-55,303 Reduced 15.47%	302,255 $1.35 Million
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $6,026 - $9,250	-2,643 Reduced 0.73%	357,558 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$3.17 - $5.96 $73,978 - $139,088	23,337 Added 6.93%	360,201 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$4.53 - $6.74 $286,232 - $425,873	63,186 Added 23.09%	336,864 $1.67 Million
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $277,138 - $462,461	56,329 Added 25.92%	273,678 $1.35 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $729,588 - $1.44 Million	-129,820 Reduced 37.39%	217,349 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $2.34 Million - $3.93 Million	-227,183 Reduced 39.55%	347,169 $3.75 Million
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $715,079 - $1.3 Million	-105,469 Reduced 15.51%	574,352 $6.55 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $2.59 Million - $5.18 Million	338,767 Added 99.33%	679,821 $6.45 Million
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $1.37 Million - $2.56 Million	-104,476 Reduced 23.45%	341,054 $5.09 Million
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $2.69 Million - $3.54 Million	-128,074 Reduced 22.33%	445,530 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $8.12 Million - $12.4 Million	345,555 Added 151.53%	573,604 $15 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $188,679 - $285,470	-7,316 Reduced 3.11%	228,049 $8.05 Million
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $2.98 Million - $5.13 Million	-118,130 Reduced 33.42%	235,365 $5.94 Million
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $335,910 - $466,415	-10,374 Reduced 2.85%	353,495 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $3.89 Million - $11.4 Million	211,485 Added 138.78%	363,869 $15.6 Million
Q1 2020 May 14, 2020	BUY	$18.22 - $28.25 $28,951 - $44,889	1,589 Added 1.05%	152,384 $2.96 Million
Q4 2019 Feb 14, 2020	SELL	$24.82 - $31.4 $10.5 Million - $13.3 Million	-422,232 Reduced 73.68%	150,795 $3.92 Million
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $407,185 - $514,479	15,595 Added 2.8%	573,027 $15.6 Million
Q2 2019 Aug 15, 2019	BUY	$25.56 - $31.09 $14.2 Million - $17.3 Million	557,432 New	557,432 $15 Million

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

132M

Call Options Held

94.3K

Put Options Held

112K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $418M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Allogene Therapeutics, Inc. Transaction History